Compare iShares S&P GSCI Commodity-Indexed Trust ETF (GSG) vs Tempus AI (TEM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
iShares S&P GSCI Commodity-Indexed Trust ETF vs Tempus AI — how do they compare? iShares S&P GSCI Commodity-Indexed Trust ETF trades at $30.85, while Tempus AI trades at $53.1 (market cap $10.28B). The key difference: iShares S&P GSCI Commodity-Indexed Trust ETF is trading nearer its 52-week high, Tempus AI nearer its low. Which is the better fit depends on your goals.
| GSG | TEM | |
|---|---|---|
Sector | Commodities - Metals/Agriculture | Broad Market / Factor |
52-Week High | $34.77 | $103.25 |
52-Week Low | $22.06 | $42.37 |
Market Cap | — | $10.28B |
Enterprise Value | — | $10.96B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GSG, the iShares S&P GSCI Commodity-Indexed Trust ETF, trades at $30.85, down 0.48% on the day. Technical indicators show a bullish trend with moving averages strongly positive, though oscillators are neutral and short-term RSI signals suggest overbought conditions. Recent financial media highlights a thematic focus on commodities as a key market driver, with notable investors increasing exposure to the sector.
The outlook for GSG is tied to commodity price trends and broader economic developments. Investment opportunity lies in exposure to a constrained supply environment and inflation hedging. Primary risks include commodity price volatility, global economic slowdowns reducing demand, and the ETF's structure leading to tracking error or contango in futures markets.
Tempus AI (TEM) trades at $53.69, down 8.39% over 24 hours, with a neutral technical signal despite bullish moving averages. The company shows strong revenue growth ($1.27B in 2025) and consistent earnings beats, but remains unprofitable with negative net income margins (-22.2%). Recent news highlights AI deployment in healthcare systems and FDA clearances, supporting its data-driven healthcare platform.
The outlook balances high-growth potential in AI healthcare data against persistent profitability challenges. Analyst consensus is bullish with a $68.50 price target, but investors face risks from ongoing cash burn, competitive pressures, and execution hurdles as the company scales its platform toward sustainable margins.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About iShares S&P GSCI Commodity-Indexed Trust ETF
GSG is a diversified commodity ETF that tracks the S&P GSCI Total Return Index. It provides exposure to a broad basket of futures, including energy, metals, and agriculture, with a significant weighting toward the energy sector.
Read more on GSG →About Tempus AI
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
Read more on TEM →
